• HOME>
  • News Room>
  • News Releases>
  • Sumitomo Dainippon Pharma announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

News Releases

Dec. 01, 2015 Print(PDF/101KB)Corporate

Sumitomo Dainippon Pharma announces Organizational Realignment and Changes in Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co.,Ltd.(Head Office:Osaka,Japan;President:Masayo Tada)today announced that the following organizational realignment and changes in Executive Officers and other key positions will take place effective January 1,2016:

I.Organizational Realignment(effective January 1,2016)

  • Corporate Departments
    • 1.Oncology Clinical Development Unit is created.
    • 2.Oncology Medical & Marketing Unit is created.
  • Drug Development(Division)

    Oncology Clinical Development Unit is dissolved.

  • Sales & Marketing(Division)

    Oncology Marketing Unit is dissolved.

II.Changes in Executive Officers

Changes in the posts assumed by Executive Officers(effective January 1,2016)
Post as of January 1,2016Current postName
Representative Director,President and Chief Executive Officer Representative Director,President and Chief Executive Officer
Executive Director,Drug Development		 Masayo Tada
Member,Board of Directors,Senior Executive Officer
Global Corporate Planning;Global Business Development;External Affairs;Corporate Secretariat & Industry Affairs;Finance & Accounting;Regenerative & Cellular Medicine Office;Drug Development		 Member,Board of Directors,Senior Executive Officer
Global Corporate Planning;Global Business Development;External Affairs;Corporate Secretariat & Industry Affairs;Finance & Accounting;Regenerative & Cellular Medicine Office		 Hiroshi Nomura
Executive Officer
Executive Director,Drug Development		 Executive Officer
Deputy Executive Director,Drug Development		 Nobuyuki Hara

III.Changes in Personnel(effective January 1,2016)

Position as of January 1,2016Current positionName
Director,Drug Development Research Laboratories
Director,Preclinical Research Laboratories		 Director,Drug Development Research Laboratories Isao Shimizu
Director,Oncology Clinical Development Unit Director,Oncology Clinical Development Unit Haruhiko Koike
Director,Oncology Medical & Marketing Unit Director,Oncology Marketing Unit Masayuki Uchibori
Director,Manufacturing Management Director,Procurement Director,Ibaraki Plant Kenji Ueno
Director,Ibaraki Plant Director,Manufacturing Technology Hiroyuki Nishii
Director,Manufacturing Technology Group Manager,Pharmaceutical Technology Suzuka Group Mitsuhito Kondo